-+ 0.00%
-+ 0.00%
-+ 0.00%

LifeSci Capital Initiates Coverage On Veradermics with Outperform Rating, Announces Price Target of $135

Benzinga·06/16/2026 16:51:23
Listen to the news
LifeSci Capital analyst Rami Katkhuda initiates coverage on Veradermics (NYSE:MANE) with a Outperform rating and announces Price Target of $135.